Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Fluocinolone-acetonide

Ocular hypertension: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Pacella F, et al. Efficacy and safety of intravitreal Fluocinolone Acetonide microimplant (ILUVIEN) in patients with chronic diabetic macular edema: 1 year follow-up. European Journal of Ophthalmology 32 : 1109-1113, No. 2, Mar 2022. Available from: URL: https://journals.sagepub.com/home/EJO Pacella F, et al. Efficacy and safety of intravitreal Fluocinolone Acetonide microimplant (ILUVIEN) in patients with chronic diabetic macular edema: 1 year follow-up. European Journal of Ophthalmology 32 : 1109-1113, No. 2, Mar 2022. Available from: URL: https://​journals.​sagepub.​com/​home/​EJO
Metadaten
Titel
Fluocinolone-acetonide
Ocular hypertension: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41863-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antibacterials

Case report

Rituximab